Modernize Biopharmaceutical QC Testing to Increase Efficiency
How does the Octet system stack up in method validation for ligand binding and potency assays?
Up to 2x faster* and with the ability to process 40x more samples per day*, Octet BLI technology is an ideal replacement for ELISA, SPR, and HPLC techniques for the quantification of antibodies and recombinant proteins, and is especially suitable for product potency lot release assays.
Our newest application overview shares the success at Boehringer Ingelheim, where they were able to develop an active Fab quantitation assay for in-process testing as well as stability and lot release testing in less than one week using the Octet platform. Octet systems enable users to complete qualification, validation, and support solutions that fulfill stringent requirements, while still allowing rapid development, optimization, and validation of assay methods.
